Latest filing published 26 May 2026 for Progyny, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Elizabeth D. Bierbower has 40 filings for trades running from September 1, 2017 to May 21, 2026: at Humana Inc (33, title Strategic Advisor), at Option Care Health, Inc. (6, Director) and at Progyny, Inc. (1, Director). The record holds 18 option exercises, 14 grants, 7 sales and one purchase.
Sales make up most of the amounts: EUR 14,010,272 in all, median EUR 1,774,121. The two largest follow each other a week apart in December 2019, at Humana Inc: EUR 4,603,999 on December 13 and EUR 2,931,165 on December 6. The third, EUR 2,128,029, is dated September 1, 2017. The single purchase is EUR 74,897, on October 30, 2023, at Option Care Health, Inc.
Activity is concentrated in 2018 (13 filings) and 2019 (17). It then falls to 1 or 2 a year. The 2 filings of the last twelve months are neither purchases nor sales.
The median publication delay is 3 days. Bierbower has 6, 6 and 5 own market trades within 30 days of colleagues at Humana Inc, in that order. All of them in the same direction. The colleagues, in the same order: Cynthia H. Zipperle, William Kevin Fleming and Brian P. LeClaire.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 40 declarations